Advair Powder
Product Images NDC 50090-4505

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Advair (NDC 50090-4505). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fluticasone Propionate Chemical Structure (Advair Diskus Spl Graphic 01)

FDA Label Image

Salmeterol Xinafoate Chemical Structure (Advair Diskus Spl Graphic 02)

FDA Label Image

Figure 1. Mean Percent Change From Baseline In Fev1 In Subjects With Asthma Previously Treated With Either Inhaled Corticosteroids Or Salmeterol (trial 1) (Advair Diskus Spl Graphic 03)

FDA Label Image

S:\project Files\a\advair Diskus Nda 021077\figures\advair-diskus-spl-graphic-04.jpg (Advair Diskus Spl Graphic 04)

FDA Label Image

Figure 3. Percent Change In Serial 12-hour Fev1 In Subjects With Asthma Previously Using Either Inhaled Corticosteroids Or Salmeterol (trial 1) (Advair Diskus Spl Graphic 05)

This text seems to mention the dosages and usage instructions for a medication called ADVAIR DISKUS 100D. It includes details such as the frequency of administration and the type of medication present in the diskus. The text also refers to parameters like "Change in FEV1", which could relate to pulmonary health monitoring.*

FDA Label Image

Figure 4. Predose Fev1: Mean Percent Change From Baseline In Subjects With Chronic Obstructive Pulmonary Disease (Advair Diskus Spl Graphic 06)

FDA Label Image

Figure 5. Two-hour Postdose Fev1: Mean Percent Changes From Baseline Over Time In Subjects With Chronic Obstructive Pulmonary Disease (Advair Diskus Spl Graphic 07)

FDA Label Image

Figure A (Advair Diskus Spl Graphic 08)

This is a list of parts for evaluating a product, possibly a tool or a device. It includes an outer case, a mouthpiece, and a thumb grip. These components are likely part of a larger item that requires them for functionality or usability.*

FDA Label Image

Figure B (Advair Diskus Spl Graphic 09)

FDA Label Image

Figure C (Advair Diskus Spl Graphic 10)

FDA Label Image

Figure D (Advair Diskus Spl Graphic 11)

FDA Label Image

Figure E (Advair Diskus Spl Graphic 12)

FDA Label Image

Figure F (Advair Diskus Spl Graphic 13)

FDA Label Image

Figure G (Advair Diskus Spl Graphic 14)

FDA Label Image

Figure H (Advair Diskus Spl Graphic 15)

FDA Label Image

Label Image (Lbl500904505)

This text provides details on a medication product called Advair Diskus, an inhalation powder containing Fluticasone Propionate and Salmeterol Xinafoate. Each blister has 500 mcg of Fluticasone Propionate and 72.5 mg of Salmeterol Xinafoate. The product should be stored between 68 to 77 degrees Fahrenheit, away from heat and sunlight. The package includes one Diskus inhalation device containing a foil strip of 60 blisters. Distributed by AS Medication Solutions in Libertyville, IL. This product is for prescription use only. NDC: 50090-4505-0.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.